{"id":"NCT00788372","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain","officialTitle":"A Long-Term Study of JNS020QD in Patients With Chronic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2008-11-10","resultsPosted":"2013-06-26","lastUpdate":"2013-06-26"},"enrollment":142,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pain"],"interventions":[{"type":"DRUG","name":"Fentanyl","otherNames":["JNS020QD"]}],"arms":[{"label":"Fentanyl","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of fentanyl one-day transdermal patch (JNS020QD, patch containing a drug that is put on the skin so the drug will enter the body through the skin) in participants with chronic (lasting a long time) pain.","primaryOutcome":{"measure":"Questionnaire of Opioid Withdrawal Symptoms","timeFrame":"Week 52 or endpoint (1 week after last treatment or early discontinuation)","effectByArm":[{"arm":"Fentanyl","deltaMin":137,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":23,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":142},"commonTop":["Somnolence","Constipation","Nausea","Dizziness","Nasopharyngitis"]}}